542934 — Chandra Bhagat Pharma Cashflow Statement
0.000.00%
- IN₹452.70m
- IN₹650.49m
- IN₹2.21bn
- 52
- 41
- 13
- 24
Annual cashflow statement for Chandra Bhagat Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 4.22 | 2.79 | 11 | 11.6 | 22.6 |
Depreciation | |||||
Non-Cash Items | 26.6 | 34.3 | 29.9 | 20.8 | 13.8 |
Other Non-Cash Items | |||||
Changes in Working Capital | -105 | 39.5 | 83.4 | 19.1 | 20.5 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -74.1 | 76.9 | 125 | 52.6 | 61.8 |
Capital Expenditures | -0.038 | -0.203 | -0.998 | -3.69 | -22.8 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.54 | 1.39 | 1.85 | 3.1 | 4.29 |
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.502 | 1.19 | 0.854 | -0.59 | -18.5 |
Financing Cash Flow Items | 56.9 | -34.8 | -30.8 | -21.9 | -13.9 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 69.4 | -54.4 | -96.2 | -44.5 | -58 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -4.26 | 23.7 | 29.2 | 7.58 | -14.8 |